February 11, 2015
11am-12:30pm est

Sponsored by

Webinar Description:

Increasing efficiency and productivity for product titer quantification is even more critical as a result of increasing workloads in supporting multiple programs at different stages with limited resources. Current methods, such as ELISA and HPLC, create bottlenecks in critical workflows because of throughput constraints, limited dynamic range, and longer assay times. In addition, in process analytical testing needs to accommodate different sample types, matrices and a variety of conditions that are variable throughout cell line development and upstream development. Gyros’ technology provides a robust, reproducible alternative to improve analytical support to the ever increasing demands to control product quality and process consistency that is scalable at all stages of development and production. This webinar will focus on the use of automated, nanoliter-scale flow-through technology to address a critical need for improved speed and throughput with high data quality for product titer quantification.

Speaker 1:

Rapid Development of Gyrolab Titer ELISAs to Support Biopharmaceutical Process Development

Matt Traylor, Analytical Development, Shire Human Genetic Therapies

Speaker 2:

High Throughput Monoclonal Antibody Titer Assay for BioProcess Development

Jun Heo, Analytical Scientist, Bioprocess Technology and Expression (BTE), Merck & Co., Inc.


Meletios Roussis, Field Applications Scientist, Gyros US, Inc.

Schedule conflict? Register now and you'll receive a copy of the recording